Successful management of infusion reaction accompanying the start of cetuximab therapy
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11150%2F07%3A00003580" target="_blank" >RIV/00216208:11150/07:00003580 - isvavai.cz</a>
Alternative codes found
RIV/00179906:_____/07:00000239
Result on the web
—
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Successful management of infusion reaction accompanying the start of cetuximab therapy
Original language description
Cetuximab is a chimeric antibody registrated for the therapy of advanced colorectal carcinoma after failure of standard chemotherapy.
Czech name
Úspěšně vedené infuze, doprovázené zahájením léčby cetuximabem
Czech description
Cetuximab je chimerickou protilátkou registrovanou pro léčbu kolorektálního karcinomu při neúspěšné standartní chemoterapii.
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FD - Oncology and haematology
OECD FORD branch
—
Result continuities
Project
—
Continuities
Z - Vyzkumny zamer (s odkazem do CEZ)
Others
Publication year
2007
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Supportive Care in Cancer
ISSN
0941-4355
e-ISSN
—
Volume of the periodical
15
Issue of the periodical within the volume
4
Country of publishing house
US - UNITED STATES
Number of pages
5
Pages from-to
445-449
UT code for WoS article
—
EID of the result in the Scopus database
—